PR

Precision Biosensor Inc.

Develops sensitive point-of-care biomarker diagnostics for human and animal health.

335810 | KO

Overview

Corporate Details

ISIN(s):
KR7335810008
LEI:
Country:
South Korea
Address:
대전시 유성구 테크노2로 306, 대전시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Precision Biosensor Inc. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells point-of-care testing (POCT) solutions. The company specializes in biomarker diagnostics, offering a range of clinical diagnostic products for both human and animal healthcare. Its core offerings are built upon a proprietary time-resolved fluorescence (TRF) immunoassay technology, designed to deliver highly sensitive and accurate results for on-site diagnosis. The product line includes diagnostic devices and reagents for immuno-diagnosis and clinical chemistry, aiming to provide optimized solutions for rapid clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-01 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.6 KB
2025-07-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.4 KB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.1 KB
2025-04-02 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 23.2 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.1 KB
2025-03-27 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.8 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 491.4 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 156.0 KB

Automate Your Workflow. Get a real-time feed of all Precision Biosensor Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Precision Biosensor Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Precision Biosensor Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CEL SCI CORP Logo
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea
083790
CG Oncology, Inc. Logo
Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea
261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea
052670

Talk to a Data Expert

Have a question? We'll get back to you promptly.